B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

EPHX2

MOLECULAR TARGET

epoxide hydrolase 2

UniProt: P34913NCBI Gene: 205321 compounds

EPHX2 (epoxide hydrolase 2) is targeted by 21 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting EPHX2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1zileuton5.04154
2ebselen4.74113
3isoquercetin4.5089
4urb 5974.0858
5quercitrin3.9752
6zafirlukast3.8948
7phlorizin3.7843
8regorafenib3.5634
9hyperoside3.5634
10aloe emodin3.4330
11talinolol3.3026
12ar92812.7114
13diphenylurea2.309
14atreleuton2.087
1513 dicyclohexylurea2.087
16triclocarban1.795
17Fulvestrant1.393
18Sorafenib1.102
19cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester [Supplementary Concept]1.102
20obeticholic acid [Supplementary Concept]0.691
21Sodium Dodecyl Sulfate0.691

About EPHX2 as a Drug Target

EPHX2 (epoxide hydrolase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 21 compounds with documented EPHX2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

EPHX2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.